Retraction
Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
Paper Information
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Informed/Patient Consent - None/Withdrawn
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9756013Additional Notes:
See also: https://pubpeer.com/publications/F6452F1FDFAB5913FD43BF87A1BE57
Citations (3)
3
Total Citations0
Post-Retraction2
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism
Xiaoxiao Xing, Jianbo Guo, Juefei Mo et al. (14 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: Jan 2023
7 citations
7 citations
252 days before retraction
Retracted: Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
262 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025